Global Faecal Microbiota Transplant(FMT) Therapy Supply, Demand and Key Producers, 2023-2029
This report studies the global Faecal Microbiota Transplant(FMT) Therapy demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Faecal Microbiota Transplant(FMT) Therapy, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Faecal Microbiota Transplant(FMT) Therapy that contribute to its increasing demand across many markets.
The global Faecal Microbiota Transplant(FMT) Therapy market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
Highlights and key features of the study
Global Faecal Microbiota Transplant(FMT) Therapy total market, 2018-2029, (USD Million)
Global Faecal Microbiota Transplant(FMT) Therapy total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Faecal Microbiota Transplant(FMT) Therapy total market, key domestic companies and share, (USD Million)
Global Faecal Microbiota Transplant(FMT) Therapy revenue by player and market share 2018-2023, (USD Million)
Global Faecal Microbiota Transplant(FMT) Therapy total market by Type, CAGR, 2018-2029, (USD Million)
Global Faecal Microbiota Transplant(FMT) Therapy total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Faecal Microbiota Transplant(FMT) Therapy market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Enterome Bioscience, Rebiotix, Ritter Pharmaceuticals, Finch Therapeutics, Crestovo, Maat Pharma, Seres Therapeutics, Second Genome and OpenBiome, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Faecal Microbiota Transplant(FMT) Therapy market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Faecal Microbiota Transplant(FMT) Therapy Market, By Region:
1. How big is the global Faecal Microbiota Transplant(FMT) Therapy market?
2. What is the demand of the global Faecal Microbiota Transplant(FMT) Therapy market?
3. What is the year over year growth of the global Faecal Microbiota Transplant(FMT) Therapy market?
4. What is the total value of the global Faecal Microbiota Transplant(FMT) Therapy market?
5. Who are the major players in the global Faecal Microbiota Transplant(FMT) Therapy market?
6. What are the growth factors driving the market demand?
This report is a detailed and comprehensive analysis of the world market for Faecal Microbiota Transplant(FMT) Therapy, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Faecal Microbiota Transplant(FMT) Therapy that contribute to its increasing demand across many markets.
The global Faecal Microbiota Transplant(FMT) Therapy market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
Highlights and key features of the study
Global Faecal Microbiota Transplant(FMT) Therapy total market, 2018-2029, (USD Million)
Global Faecal Microbiota Transplant(FMT) Therapy total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Faecal Microbiota Transplant(FMT) Therapy total market, key domestic companies and share, (USD Million)
Global Faecal Microbiota Transplant(FMT) Therapy revenue by player and market share 2018-2023, (USD Million)
Global Faecal Microbiota Transplant(FMT) Therapy total market by Type, CAGR, 2018-2029, (USD Million)
Global Faecal Microbiota Transplant(FMT) Therapy total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Faecal Microbiota Transplant(FMT) Therapy market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Enterome Bioscience, Rebiotix, Ritter Pharmaceuticals, Finch Therapeutics, Crestovo, Maat Pharma, Seres Therapeutics, Second Genome and OpenBiome, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Faecal Microbiota Transplant(FMT) Therapy market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Faecal Microbiota Transplant(FMT) Therapy Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Oral
- Enema
- Clostridioides Difficile Infection(CDI)
- Digestive System Disease
- Nervous System Disease
- Others
- Enterome Bioscience
- Rebiotix
- Ritter Pharmaceuticals
- Finch Therapeutics
- Crestovo
- Maat Pharma
- Seres Therapeutics
- Second Genome
- OpenBiome
- MicroBiome Therapeutics
1. How big is the global Faecal Microbiota Transplant(FMT) Therapy market?
2. What is the demand of the global Faecal Microbiota Transplant(FMT) Therapy market?
3. What is the year over year growth of the global Faecal Microbiota Transplant(FMT) Therapy market?
4. What is the total value of the global Faecal Microbiota Transplant(FMT) Therapy market?
5. Who are the major players in the global Faecal Microbiota Transplant(FMT) Therapy market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Faecal Microbiota Transplant(FMT) Therapy Introduction
1.2 World Faecal Microbiota Transplant(FMT) Therapy Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Faecal Microbiota Transplant(FMT) Therapy Total Market by Region (by Headquarter Location)
1.3.1 World Faecal Microbiota Transplant(FMT) Therapy Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Faecal Microbiota Transplant(FMT) Therapy Market Size (2018-2029)
1.3.3 China Faecal Microbiota Transplant(FMT) Therapy Market Size (2018-2029)
1.3.4 Europe Faecal Microbiota Transplant(FMT) Therapy Market Size (2018-2029)
1.3.5 Japan Faecal Microbiota Transplant(FMT) Therapy Market Size (2018-2029)
1.3.6 South Korea Faecal Microbiota Transplant(FMT) Therapy Market Size (2018-2029)
1.3.7 ASEAN Faecal Microbiota Transplant(FMT) Therapy Market Size (2018-2029)
1.3.8 India Faecal Microbiota Transplant(FMT) Therapy Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Faecal Microbiota Transplant(FMT) Therapy Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Faecal Microbiota Transplant(FMT) Therapy Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Faecal Microbiota Transplant(FMT) Therapy Consumption Value (2018-2029)
2.2 World Faecal Microbiota Transplant(FMT) Therapy Consumption Value by Region
2.2.1 World Faecal Microbiota Transplant(FMT) Therapy Consumption Value by Region (2018-2023)
2.2.2 World Faecal Microbiota Transplant(FMT) Therapy Consumption Value Forecast by Region (2024-2029)
2.3 United States Faecal Microbiota Transplant(FMT) Therapy Consumption Value (2018-2029)
2.4 China Faecal Microbiota Transplant(FMT) Therapy Consumption Value (2018-2029)
2.5 Europe Faecal Microbiota Transplant(FMT) Therapy Consumption Value (2018-2029)
2.6 Japan Faecal Microbiota Transplant(FMT) Therapy Consumption Value (2018-2029)
2.7 South Korea Faecal Microbiota Transplant(FMT) Therapy Consumption Value (2018-2029)
2.8 ASEAN Faecal Microbiota Transplant(FMT) Therapy Consumption Value (2018-2029)
2.9 India Faecal Microbiota Transplant(FMT) Therapy Consumption Value (2018-2029)
3 WORLD FAECAL MICROBIOTA TRANSPLANT(FMT) THERAPY COMPANIES COMPETITIVE ANALYSIS
3.1 World Faecal Microbiota Transplant(FMT) Therapy Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Faecal Microbiota Transplant(FMT) Therapy Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Faecal Microbiota Transplant(FMT) Therapy in 2022
3.2.3 Global Concentration Ratios (CR8) for Faecal Microbiota Transplant(FMT) Therapy in 2022
3.3 Faecal Microbiota Transplant(FMT) Therapy Company Evaluation Quadrant
3.4 Faecal Microbiota Transplant(FMT) Therapy Market: Overall Company Footprint Analysis
3.4.1 Faecal Microbiota Transplant(FMT) Therapy Market: Region Footprint
3.4.2 Faecal Microbiota Transplant(FMT) Therapy Market: Company Product Type Footprint
3.4.3 Faecal Microbiota Transplant(FMT) Therapy Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Faecal Microbiota Transplant(FMT) Therapy Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Faecal Microbiota Transplant(FMT) Therapy Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Faecal Microbiota Transplant(FMT) Therapy Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Faecal Microbiota Transplant(FMT) Therapy Consumption Value Comparison
4.2.1 United States VS China: Faecal Microbiota Transplant(FMT) Therapy Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Faecal Microbiota Transplant(FMT) Therapy Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Faecal Microbiota Transplant(FMT) Therapy Companies and Market Share, 2018-2023
4.3.1 United States Based Faecal Microbiota Transplant(FMT) Therapy Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Faecal Microbiota Transplant(FMT) Therapy Revenue, (2018-2023)
4.4 China Based Companies Faecal Microbiota Transplant(FMT) Therapy Revenue and Market Share, 2018-2023
4.4.1 China Based Faecal Microbiota Transplant(FMT) Therapy Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Faecal Microbiota Transplant(FMT) Therapy Revenue, (2018-2023)
4.5 Rest of World Based Faecal Microbiota Transplant(FMT) Therapy Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Faecal Microbiota Transplant(FMT) Therapy Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Faecal Microbiota Transplant(FMT) Therapy Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Faecal Microbiota Transplant(FMT) Therapy Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Oral
5.2.2 Enema
5.3 Market Segment by Type
5.3.1 World Faecal Microbiota Transplant(FMT) Therapy Market Size by Type (2018-2023)
5.3.2 World Faecal Microbiota Transplant(FMT) Therapy Market Size by Type (2024-2029)
5.3.3 World Faecal Microbiota Transplant(FMT) Therapy Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Faecal Microbiota Transplant(FMT) Therapy Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Clostridioides Difficile Infection(CDI)
6.2.2 Digestive System Disease
6.2.3 Nervous System Disease
6.2.4 Others
6.2.5 Others
6.3 Market Segment by Application
6.3.1 World Faecal Microbiota Transplant(FMT) Therapy Market Size by Application (2018-2023)
6.3.2 World Faecal Microbiota Transplant(FMT) Therapy Market Size by Application (2024-2029)
6.3.3 World Faecal Microbiota Transplant(FMT) Therapy Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Enterome Bioscience
7.1.1 Enterome Bioscience Details
7.1.2 Enterome Bioscience Major Business
7.1.3 Enterome Bioscience Faecal Microbiota Transplant(FMT) Therapy Product and Services
7.1.4 Enterome Bioscience Faecal Microbiota Transplant(FMT) Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Enterome Bioscience Recent Developments/Updates
7.1.6 Enterome Bioscience Competitive Strengths & Weaknesses
7.2 Rebiotix
7.2.1 Rebiotix Details
7.2.2 Rebiotix Major Business
7.2.3 Rebiotix Faecal Microbiota Transplant(FMT) Therapy Product and Services
7.2.4 Rebiotix Faecal Microbiota Transplant(FMT) Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Rebiotix Recent Developments/Updates
7.2.6 Rebiotix Competitive Strengths & Weaknesses
7.3 Ritter Pharmaceuticals
7.3.1 Ritter Pharmaceuticals Details
7.3.2 Ritter Pharmaceuticals Major Business
7.3.3 Ritter Pharmaceuticals Faecal Microbiota Transplant(FMT) Therapy Product and Services
7.3.4 Ritter Pharmaceuticals Faecal Microbiota Transplant(FMT) Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Ritter Pharmaceuticals Recent Developments/Updates
7.3.6 Ritter Pharmaceuticals Competitive Strengths & Weaknesses
7.4 Finch Therapeutics
7.4.1 Finch Therapeutics Details
7.4.2 Finch Therapeutics Major Business
7.4.3 Finch Therapeutics Faecal Microbiota Transplant(FMT) Therapy Product and Services
7.4.4 Finch Therapeutics Faecal Microbiota Transplant(FMT) Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Finch Therapeutics Recent Developments/Updates
7.4.6 Finch Therapeutics Competitive Strengths & Weaknesses
7.5 Crestovo
7.5.1 Crestovo Details
7.5.2 Crestovo Major Business
7.5.3 Crestovo Faecal Microbiota Transplant(FMT) Therapy Product and Services
7.5.4 Crestovo Faecal Microbiota Transplant(FMT) Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Crestovo Recent Developments/Updates
7.5.6 Crestovo Competitive Strengths & Weaknesses
7.6 Maat Pharma
7.6.1 Maat Pharma Details
7.6.2 Maat Pharma Major Business
7.6.3 Maat Pharma Faecal Microbiota Transplant(FMT) Therapy Product and Services
7.6.4 Maat Pharma Faecal Microbiota Transplant(FMT) Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Maat Pharma Recent Developments/Updates
7.6.6 Maat Pharma Competitive Strengths & Weaknesses
7.7 Seres Therapeutics
7.7.1 Seres Therapeutics Details
7.7.2 Seres Therapeutics Major Business
7.7.3 Seres Therapeutics Faecal Microbiota Transplant(FMT) Therapy Product and Services
7.7.4 Seres Therapeutics Faecal Microbiota Transplant(FMT) Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Seres Therapeutics Recent Developments/Updates
7.7.6 Seres Therapeutics Competitive Strengths & Weaknesses
7.8 Second Genome
7.8.1 Second Genome Details
7.8.2 Second Genome Major Business
7.8.3 Second Genome Faecal Microbiota Transplant(FMT) Therapy Product and Services
7.8.4 Second Genome Faecal Microbiota Transplant(FMT) Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Second Genome Recent Developments/Updates
7.8.6 Second Genome Competitive Strengths & Weaknesses
7.9 OpenBiome
7.9.1 OpenBiome Details
7.9.2 OpenBiome Major Business
7.9.3 OpenBiome Faecal Microbiota Transplant(FMT) Therapy Product and Services
7.9.4 OpenBiome Faecal Microbiota Transplant(FMT) Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 OpenBiome Recent Developments/Updates
7.9.6 OpenBiome Competitive Strengths & Weaknesses
7.10 MicroBiome Therapeutics
7.10.1 MicroBiome Therapeutics Details
7.10.2 MicroBiome Therapeutics Major Business
7.10.3 MicroBiome Therapeutics Faecal Microbiota Transplant(FMT) Therapy Product and Services
7.10.4 MicroBiome Therapeutics Faecal Microbiota Transplant(FMT) Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 MicroBiome Therapeutics Recent Developments/Updates
7.10.6 MicroBiome Therapeutics Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Faecal Microbiota Transplant(FMT) Therapy Industry Chain
8.2 Faecal Microbiota Transplant(FMT) Therapy Upstream Analysis
8.3 Faecal Microbiota Transplant(FMT) Therapy Midstream Analysis
8.4 Faecal Microbiota Transplant(FMT) Therapy Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Faecal Microbiota Transplant(FMT) Therapy Introduction
1.2 World Faecal Microbiota Transplant(FMT) Therapy Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Faecal Microbiota Transplant(FMT) Therapy Total Market by Region (by Headquarter Location)
1.3.1 World Faecal Microbiota Transplant(FMT) Therapy Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Faecal Microbiota Transplant(FMT) Therapy Market Size (2018-2029)
1.3.3 China Faecal Microbiota Transplant(FMT) Therapy Market Size (2018-2029)
1.3.4 Europe Faecal Microbiota Transplant(FMT) Therapy Market Size (2018-2029)
1.3.5 Japan Faecal Microbiota Transplant(FMT) Therapy Market Size (2018-2029)
1.3.6 South Korea Faecal Microbiota Transplant(FMT) Therapy Market Size (2018-2029)
1.3.7 ASEAN Faecal Microbiota Transplant(FMT) Therapy Market Size (2018-2029)
1.3.8 India Faecal Microbiota Transplant(FMT) Therapy Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Faecal Microbiota Transplant(FMT) Therapy Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Faecal Microbiota Transplant(FMT) Therapy Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Faecal Microbiota Transplant(FMT) Therapy Consumption Value (2018-2029)
2.2 World Faecal Microbiota Transplant(FMT) Therapy Consumption Value by Region
2.2.1 World Faecal Microbiota Transplant(FMT) Therapy Consumption Value by Region (2018-2023)
2.2.2 World Faecal Microbiota Transplant(FMT) Therapy Consumption Value Forecast by Region (2024-2029)
2.3 United States Faecal Microbiota Transplant(FMT) Therapy Consumption Value (2018-2029)
2.4 China Faecal Microbiota Transplant(FMT) Therapy Consumption Value (2018-2029)
2.5 Europe Faecal Microbiota Transplant(FMT) Therapy Consumption Value (2018-2029)
2.6 Japan Faecal Microbiota Transplant(FMT) Therapy Consumption Value (2018-2029)
2.7 South Korea Faecal Microbiota Transplant(FMT) Therapy Consumption Value (2018-2029)
2.8 ASEAN Faecal Microbiota Transplant(FMT) Therapy Consumption Value (2018-2029)
2.9 India Faecal Microbiota Transplant(FMT) Therapy Consumption Value (2018-2029)
3 WORLD FAECAL MICROBIOTA TRANSPLANT(FMT) THERAPY COMPANIES COMPETITIVE ANALYSIS
3.1 World Faecal Microbiota Transplant(FMT) Therapy Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Faecal Microbiota Transplant(FMT) Therapy Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Faecal Microbiota Transplant(FMT) Therapy in 2022
3.2.3 Global Concentration Ratios (CR8) for Faecal Microbiota Transplant(FMT) Therapy in 2022
3.3 Faecal Microbiota Transplant(FMT) Therapy Company Evaluation Quadrant
3.4 Faecal Microbiota Transplant(FMT) Therapy Market: Overall Company Footprint Analysis
3.4.1 Faecal Microbiota Transplant(FMT) Therapy Market: Region Footprint
3.4.2 Faecal Microbiota Transplant(FMT) Therapy Market: Company Product Type Footprint
3.4.3 Faecal Microbiota Transplant(FMT) Therapy Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Faecal Microbiota Transplant(FMT) Therapy Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Faecal Microbiota Transplant(FMT) Therapy Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Faecal Microbiota Transplant(FMT) Therapy Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Faecal Microbiota Transplant(FMT) Therapy Consumption Value Comparison
4.2.1 United States VS China: Faecal Microbiota Transplant(FMT) Therapy Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Faecal Microbiota Transplant(FMT) Therapy Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Faecal Microbiota Transplant(FMT) Therapy Companies and Market Share, 2018-2023
4.3.1 United States Based Faecal Microbiota Transplant(FMT) Therapy Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Faecal Microbiota Transplant(FMT) Therapy Revenue, (2018-2023)
4.4 China Based Companies Faecal Microbiota Transplant(FMT) Therapy Revenue and Market Share, 2018-2023
4.4.1 China Based Faecal Microbiota Transplant(FMT) Therapy Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Faecal Microbiota Transplant(FMT) Therapy Revenue, (2018-2023)
4.5 Rest of World Based Faecal Microbiota Transplant(FMT) Therapy Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Faecal Microbiota Transplant(FMT) Therapy Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Faecal Microbiota Transplant(FMT) Therapy Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Faecal Microbiota Transplant(FMT) Therapy Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Oral
5.2.2 Enema
5.3 Market Segment by Type
5.3.1 World Faecal Microbiota Transplant(FMT) Therapy Market Size by Type (2018-2023)
5.3.2 World Faecal Microbiota Transplant(FMT) Therapy Market Size by Type (2024-2029)
5.3.3 World Faecal Microbiota Transplant(FMT) Therapy Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Faecal Microbiota Transplant(FMT) Therapy Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Clostridioides Difficile Infection(CDI)
6.2.2 Digestive System Disease
6.2.3 Nervous System Disease
6.2.4 Others
6.2.5 Others
6.3 Market Segment by Application
6.3.1 World Faecal Microbiota Transplant(FMT) Therapy Market Size by Application (2018-2023)
6.3.2 World Faecal Microbiota Transplant(FMT) Therapy Market Size by Application (2024-2029)
6.3.3 World Faecal Microbiota Transplant(FMT) Therapy Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Enterome Bioscience
7.1.1 Enterome Bioscience Details
7.1.2 Enterome Bioscience Major Business
7.1.3 Enterome Bioscience Faecal Microbiota Transplant(FMT) Therapy Product and Services
7.1.4 Enterome Bioscience Faecal Microbiota Transplant(FMT) Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Enterome Bioscience Recent Developments/Updates
7.1.6 Enterome Bioscience Competitive Strengths & Weaknesses
7.2 Rebiotix
7.2.1 Rebiotix Details
7.2.2 Rebiotix Major Business
7.2.3 Rebiotix Faecal Microbiota Transplant(FMT) Therapy Product and Services
7.2.4 Rebiotix Faecal Microbiota Transplant(FMT) Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Rebiotix Recent Developments/Updates
7.2.6 Rebiotix Competitive Strengths & Weaknesses
7.3 Ritter Pharmaceuticals
7.3.1 Ritter Pharmaceuticals Details
7.3.2 Ritter Pharmaceuticals Major Business
7.3.3 Ritter Pharmaceuticals Faecal Microbiota Transplant(FMT) Therapy Product and Services
7.3.4 Ritter Pharmaceuticals Faecal Microbiota Transplant(FMT) Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Ritter Pharmaceuticals Recent Developments/Updates
7.3.6 Ritter Pharmaceuticals Competitive Strengths & Weaknesses
7.4 Finch Therapeutics
7.4.1 Finch Therapeutics Details
7.4.2 Finch Therapeutics Major Business
7.4.3 Finch Therapeutics Faecal Microbiota Transplant(FMT) Therapy Product and Services
7.4.4 Finch Therapeutics Faecal Microbiota Transplant(FMT) Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Finch Therapeutics Recent Developments/Updates
7.4.6 Finch Therapeutics Competitive Strengths & Weaknesses
7.5 Crestovo
7.5.1 Crestovo Details
7.5.2 Crestovo Major Business
7.5.3 Crestovo Faecal Microbiota Transplant(FMT) Therapy Product and Services
7.5.4 Crestovo Faecal Microbiota Transplant(FMT) Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Crestovo Recent Developments/Updates
7.5.6 Crestovo Competitive Strengths & Weaknesses
7.6 Maat Pharma
7.6.1 Maat Pharma Details
7.6.2 Maat Pharma Major Business
7.6.3 Maat Pharma Faecal Microbiota Transplant(FMT) Therapy Product and Services
7.6.4 Maat Pharma Faecal Microbiota Transplant(FMT) Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Maat Pharma Recent Developments/Updates
7.6.6 Maat Pharma Competitive Strengths & Weaknesses
7.7 Seres Therapeutics
7.7.1 Seres Therapeutics Details
7.7.2 Seres Therapeutics Major Business
7.7.3 Seres Therapeutics Faecal Microbiota Transplant(FMT) Therapy Product and Services
7.7.4 Seres Therapeutics Faecal Microbiota Transplant(FMT) Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Seres Therapeutics Recent Developments/Updates
7.7.6 Seres Therapeutics Competitive Strengths & Weaknesses
7.8 Second Genome
7.8.1 Second Genome Details
7.8.2 Second Genome Major Business
7.8.3 Second Genome Faecal Microbiota Transplant(FMT) Therapy Product and Services
7.8.4 Second Genome Faecal Microbiota Transplant(FMT) Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Second Genome Recent Developments/Updates
7.8.6 Second Genome Competitive Strengths & Weaknesses
7.9 OpenBiome
7.9.1 OpenBiome Details
7.9.2 OpenBiome Major Business
7.9.3 OpenBiome Faecal Microbiota Transplant(FMT) Therapy Product and Services
7.9.4 OpenBiome Faecal Microbiota Transplant(FMT) Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 OpenBiome Recent Developments/Updates
7.9.6 OpenBiome Competitive Strengths & Weaknesses
7.10 MicroBiome Therapeutics
7.10.1 MicroBiome Therapeutics Details
7.10.2 MicroBiome Therapeutics Major Business
7.10.3 MicroBiome Therapeutics Faecal Microbiota Transplant(FMT) Therapy Product and Services
7.10.4 MicroBiome Therapeutics Faecal Microbiota Transplant(FMT) Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 MicroBiome Therapeutics Recent Developments/Updates
7.10.6 MicroBiome Therapeutics Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Faecal Microbiota Transplant(FMT) Therapy Industry Chain
8.2 Faecal Microbiota Transplant(FMT) Therapy Upstream Analysis
8.3 Faecal Microbiota Transplant(FMT) Therapy Midstream Analysis
8.4 Faecal Microbiota Transplant(FMT) Therapy Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Faecal Microbiota Transplant(FMT) Therapy Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Faecal Microbiota Transplant(FMT) Therapy Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Faecal Microbiota Transplant(FMT) Therapy Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Faecal Microbiota Transplant(FMT) Therapy Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Faecal Microbiota Transplant(FMT) Therapy Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Faecal Microbiota Transplant(FMT) Therapy Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Faecal Microbiota Transplant(FMT) Therapy Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Faecal Microbiota Transplant(FMT) Therapy Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Faecal Microbiota Transplant(FMT) Therapy Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Faecal Microbiota Transplant(FMT) Therapy Players in 2022
Table 12. World Faecal Microbiota Transplant(FMT) Therapy Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Faecal Microbiota Transplant(FMT) Therapy Company Evaluation Quadrant
Table 14. Head Office of Key Faecal Microbiota Transplant(FMT) Therapy Player
Table 15. Faecal Microbiota Transplant(FMT) Therapy Market: Company Product Type Footprint
Table 16. Faecal Microbiota Transplant(FMT) Therapy Market: Company Product Application Footprint
Table 17. Faecal Microbiota Transplant(FMT) Therapy Mergers & Acquisitions Activity
Table 18. United States VS China Faecal Microbiota Transplant(FMT) Therapy Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Faecal Microbiota Transplant(FMT) Therapy Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Faecal Microbiota Transplant(FMT) Therapy Companies, Headquarters (States, Country)
Table 21. United States Based Companies Faecal Microbiota Transplant(FMT) Therapy Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Faecal Microbiota Transplant(FMT) Therapy Revenue Market Share (2018-2023)
Table 23. China Based Faecal Microbiota Transplant(FMT) Therapy Companies, Headquarters (Province, Country)
Table 24. China Based Companies Faecal Microbiota Transplant(FMT) Therapy Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Faecal Microbiota Transplant(FMT) Therapy Revenue Market Share (2018-2023)
Table 26. Rest of World Based Faecal Microbiota Transplant(FMT) Therapy Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Faecal Microbiota Transplant(FMT) Therapy Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Faecal Microbiota Transplant(FMT) Therapy Revenue Market Share (2018-2023)
Table 29. World Faecal Microbiota Transplant(FMT) Therapy Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Faecal Microbiota Transplant(FMT) Therapy Market Size by Type (2018-2023) & (USD Million)
Table 31. World Faecal Microbiota Transplant(FMT) Therapy Market Size by Type (2024-2029) & (USD Million)
Table 32. World Faecal Microbiota Transplant(FMT) Therapy Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Faecal Microbiota Transplant(FMT) Therapy Market Size by Application (2018-2023) & (USD Million)
Table 34. World Faecal Microbiota Transplant(FMT) Therapy Market Size by Application (2024-2029) & (USD Million)
Table 35. Enterome Bioscience Basic Information, Area Served and Competitors
Table 36. Enterome Bioscience Major Business
Table 37. Enterome Bioscience Faecal Microbiota Transplant(FMT) Therapy Product and Services
Table 38. Enterome Bioscience Faecal Microbiota Transplant(FMT) Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Enterome Bioscience Recent Developments/Updates
Table 40. Enterome Bioscience Competitive Strengths & Weaknesses
Table 41. Rebiotix Basic Information, Area Served and Competitors
Table 42. Rebiotix Major Business
Table 43. Rebiotix Faecal Microbiota Transplant(FMT) Therapy Product and Services
Table 44. Rebiotix Faecal Microbiota Transplant(FMT) Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Rebiotix Recent Developments/Updates
Table 46. Rebiotix Competitive Strengths & Weaknesses
Table 47. Ritter Pharmaceuticals Basic Information, Area Served and Competitors
Table 48. Ritter Pharmaceuticals Major Business
Table 49. Ritter Pharmaceuticals Faecal Microbiota Transplant(FMT) Therapy Product and Services
Table 50. Ritter Pharmaceuticals Faecal Microbiota Transplant(FMT) Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Ritter Pharmaceuticals Recent Developments/Updates
Table 52. Ritter Pharmaceuticals Competitive Strengths & Weaknesses
Table 53. Finch Therapeutics Basic Information, Area Served and Competitors
Table 54. Finch Therapeutics Major Business
Table 55. Finch Therapeutics Faecal Microbiota Transplant(FMT) Therapy Product and Services
Table 56. Finch Therapeutics Faecal Microbiota Transplant(FMT) Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Finch Therapeutics Recent Developments/Updates
Table 58. Finch Therapeutics Competitive Strengths & Weaknesses
Table 59. Crestovo Basic Information, Area Served and Competitors
Table 60. Crestovo Major Business
Table 61. Crestovo Faecal Microbiota Transplant(FMT) Therapy Product and Services
Table 62. Crestovo Faecal Microbiota Transplant(FMT) Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Crestovo Recent Developments/Updates
Table 64. Crestovo Competitive Strengths & Weaknesses
Table 65. Maat Pharma Basic Information, Area Served and Competitors
Table 66. Maat Pharma Major Business
Table 67. Maat Pharma Faecal Microbiota Transplant(FMT) Therapy Product and Services
Table 68. Maat Pharma Faecal Microbiota Transplant(FMT) Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Maat Pharma Recent Developments/Updates
Table 70. Maat Pharma Competitive Strengths & Weaknesses
Table 71. Seres Therapeutics Basic Information, Area Served and Competitors
Table 72. Seres Therapeutics Major Business
Table 73. Seres Therapeutics Faecal Microbiota Transplant(FMT) Therapy Product and Services
Table 74. Seres Therapeutics Faecal Microbiota Transplant(FMT) Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Seres Therapeutics Recent Developments/Updates
Table 76. Seres Therapeutics Competitive Strengths & Weaknesses
Table 77. Second Genome Basic Information, Area Served and Competitors
Table 78. Second Genome Major Business
Table 79. Second Genome Faecal Microbiota Transplant(FMT) Therapy Product and Services
Table 80. Second Genome Faecal Microbiota Transplant(FMT) Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Second Genome Recent Developments/Updates
Table 82. Second Genome Competitive Strengths & Weaknesses
Table 83. OpenBiome Basic Information, Area Served and Competitors
Table 84. OpenBiome Major Business
Table 85. OpenBiome Faecal Microbiota Transplant(FMT) Therapy Product and Services
Table 86. OpenBiome Faecal Microbiota Transplant(FMT) Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. OpenBiome Recent Developments/Updates
Table 88. MicroBiome Therapeutics Basic Information, Area Served and Competitors
Table 89. MicroBiome Therapeutics Major Business
Table 90. MicroBiome Therapeutics Faecal Microbiota Transplant(FMT) Therapy Product and Services
Table 91. MicroBiome Therapeutics Faecal Microbiota Transplant(FMT) Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 92. Global Key Players of Faecal Microbiota Transplant(FMT) Therapy Upstream (Raw Materials)
Table 93. Faecal Microbiota Transplant(FMT) Therapy Typical Customers
List of Figure
Figure 1. Faecal Microbiota Transplant(FMT) Therapy Picture
Figure 2. World Faecal Microbiota Transplant(FMT) Therapy Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Faecal Microbiota Transplant(FMT) Therapy Total Market Size (2018-2029) & (USD Million)
Figure 4. World Faecal Microbiota Transplant(FMT) Therapy Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Faecal Microbiota Transplant(FMT) Therapy Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Faecal Microbiota Transplant(FMT) Therapy Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Faecal Microbiota Transplant(FMT) Therapy Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Faecal Microbiota Transplant(FMT) Therapy Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Faecal Microbiota Transplant(FMT) Therapy Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Faecal Microbiota Transplant(FMT) Therapy Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Faecal Microbiota Transplant(FMT) Therapy Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Faecal Microbiota Transplant(FMT) Therapy Revenue (2018-2029) & (USD Million)
Figure 13. Faecal Microbiota Transplant(FMT) Therapy Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Faecal Microbiota Transplant(FMT) Therapy Consumption Value (2018-2029) & (USD Million)
Figure 16. World Faecal Microbiota Transplant(FMT) Therapy Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Faecal Microbiota Transplant(FMT) Therapy Consumption Value (2018-2029) & (USD Million)
Figure 18. China Faecal Microbiota Transplant(FMT) Therapy Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Faecal Microbiota Transplant(FMT) Therapy Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Faecal Microbiota Transplant(FMT) Therapy Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Faecal Microbiota Transplant(FMT) Therapy Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Faecal Microbiota Transplant(FMT) Therapy Consumption Value (2018-2029) & (USD Million)
Figure 23. India Faecal Microbiota Transplant(FMT) Therapy Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Faecal Microbiota Transplant(FMT) Therapy by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Faecal Microbiota Transplant(FMT) Therapy Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Faecal Microbiota Transplant(FMT) Therapy Markets in 2022
Figure 27. United States VS China: Faecal Microbiota Transplant(FMT) Therapy Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Faecal Microbiota Transplant(FMT) Therapy Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Faecal Microbiota Transplant(FMT) Therapy Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Faecal Microbiota Transplant(FMT) Therapy Market Size Market Share by Type in 2022
Figure 31. Oral
Figure 32. Enema
Figure 33. World Faecal Microbiota Transplant(FMT) Therapy Market Size Market Share by Type (2018-2029)
Figure 34. World Faecal Microbiota Transplant(FMT) Therapy Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 35. World Faecal Microbiota Transplant(FMT) Therapy Market Size Market Share by Application in 2022
Figure 36. Clostridioides Difficile Infection(CDI)
Figure 37. Digestive System Disease
Figure 38. Nervous System Disease
Figure 39. Others
Figure 40. Faecal Microbiota Transplant(FMT) Therapy Industrial Chain
Figure 41. Methodology
Figure 42. Research Process and Data Source
Table 1. World Faecal Microbiota Transplant(FMT) Therapy Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Faecal Microbiota Transplant(FMT) Therapy Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Faecal Microbiota Transplant(FMT) Therapy Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Faecal Microbiota Transplant(FMT) Therapy Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Faecal Microbiota Transplant(FMT) Therapy Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Faecal Microbiota Transplant(FMT) Therapy Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Faecal Microbiota Transplant(FMT) Therapy Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Faecal Microbiota Transplant(FMT) Therapy Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Faecal Microbiota Transplant(FMT) Therapy Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Faecal Microbiota Transplant(FMT) Therapy Players in 2022
Table 12. World Faecal Microbiota Transplant(FMT) Therapy Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Faecal Microbiota Transplant(FMT) Therapy Company Evaluation Quadrant
Table 14. Head Office of Key Faecal Microbiota Transplant(FMT) Therapy Player
Table 15. Faecal Microbiota Transplant(FMT) Therapy Market: Company Product Type Footprint
Table 16. Faecal Microbiota Transplant(FMT) Therapy Market: Company Product Application Footprint
Table 17. Faecal Microbiota Transplant(FMT) Therapy Mergers & Acquisitions Activity
Table 18. United States VS China Faecal Microbiota Transplant(FMT) Therapy Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Faecal Microbiota Transplant(FMT) Therapy Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Faecal Microbiota Transplant(FMT) Therapy Companies, Headquarters (States, Country)
Table 21. United States Based Companies Faecal Microbiota Transplant(FMT) Therapy Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Faecal Microbiota Transplant(FMT) Therapy Revenue Market Share (2018-2023)
Table 23. China Based Faecal Microbiota Transplant(FMT) Therapy Companies, Headquarters (Province, Country)
Table 24. China Based Companies Faecal Microbiota Transplant(FMT) Therapy Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Faecal Microbiota Transplant(FMT) Therapy Revenue Market Share (2018-2023)
Table 26. Rest of World Based Faecal Microbiota Transplant(FMT) Therapy Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Faecal Microbiota Transplant(FMT) Therapy Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Faecal Microbiota Transplant(FMT) Therapy Revenue Market Share (2018-2023)
Table 29. World Faecal Microbiota Transplant(FMT) Therapy Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Faecal Microbiota Transplant(FMT) Therapy Market Size by Type (2018-2023) & (USD Million)
Table 31. World Faecal Microbiota Transplant(FMT) Therapy Market Size by Type (2024-2029) & (USD Million)
Table 32. World Faecal Microbiota Transplant(FMT) Therapy Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Faecal Microbiota Transplant(FMT) Therapy Market Size by Application (2018-2023) & (USD Million)
Table 34. World Faecal Microbiota Transplant(FMT) Therapy Market Size by Application (2024-2029) & (USD Million)
Table 35. Enterome Bioscience Basic Information, Area Served and Competitors
Table 36. Enterome Bioscience Major Business
Table 37. Enterome Bioscience Faecal Microbiota Transplant(FMT) Therapy Product and Services
Table 38. Enterome Bioscience Faecal Microbiota Transplant(FMT) Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Enterome Bioscience Recent Developments/Updates
Table 40. Enterome Bioscience Competitive Strengths & Weaknesses
Table 41. Rebiotix Basic Information, Area Served and Competitors
Table 42. Rebiotix Major Business
Table 43. Rebiotix Faecal Microbiota Transplant(FMT) Therapy Product and Services
Table 44. Rebiotix Faecal Microbiota Transplant(FMT) Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Rebiotix Recent Developments/Updates
Table 46. Rebiotix Competitive Strengths & Weaknesses
Table 47. Ritter Pharmaceuticals Basic Information, Area Served and Competitors
Table 48. Ritter Pharmaceuticals Major Business
Table 49. Ritter Pharmaceuticals Faecal Microbiota Transplant(FMT) Therapy Product and Services
Table 50. Ritter Pharmaceuticals Faecal Microbiota Transplant(FMT) Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Ritter Pharmaceuticals Recent Developments/Updates
Table 52. Ritter Pharmaceuticals Competitive Strengths & Weaknesses
Table 53. Finch Therapeutics Basic Information, Area Served and Competitors
Table 54. Finch Therapeutics Major Business
Table 55. Finch Therapeutics Faecal Microbiota Transplant(FMT) Therapy Product and Services
Table 56. Finch Therapeutics Faecal Microbiota Transplant(FMT) Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Finch Therapeutics Recent Developments/Updates
Table 58. Finch Therapeutics Competitive Strengths & Weaknesses
Table 59. Crestovo Basic Information, Area Served and Competitors
Table 60. Crestovo Major Business
Table 61. Crestovo Faecal Microbiota Transplant(FMT) Therapy Product and Services
Table 62. Crestovo Faecal Microbiota Transplant(FMT) Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Crestovo Recent Developments/Updates
Table 64. Crestovo Competitive Strengths & Weaknesses
Table 65. Maat Pharma Basic Information, Area Served and Competitors
Table 66. Maat Pharma Major Business
Table 67. Maat Pharma Faecal Microbiota Transplant(FMT) Therapy Product and Services
Table 68. Maat Pharma Faecal Microbiota Transplant(FMT) Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Maat Pharma Recent Developments/Updates
Table 70. Maat Pharma Competitive Strengths & Weaknesses
Table 71. Seres Therapeutics Basic Information, Area Served and Competitors
Table 72. Seres Therapeutics Major Business
Table 73. Seres Therapeutics Faecal Microbiota Transplant(FMT) Therapy Product and Services
Table 74. Seres Therapeutics Faecal Microbiota Transplant(FMT) Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Seres Therapeutics Recent Developments/Updates
Table 76. Seres Therapeutics Competitive Strengths & Weaknesses
Table 77. Second Genome Basic Information, Area Served and Competitors
Table 78. Second Genome Major Business
Table 79. Second Genome Faecal Microbiota Transplant(FMT) Therapy Product and Services
Table 80. Second Genome Faecal Microbiota Transplant(FMT) Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Second Genome Recent Developments/Updates
Table 82. Second Genome Competitive Strengths & Weaknesses
Table 83. OpenBiome Basic Information, Area Served and Competitors
Table 84. OpenBiome Major Business
Table 85. OpenBiome Faecal Microbiota Transplant(FMT) Therapy Product and Services
Table 86. OpenBiome Faecal Microbiota Transplant(FMT) Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. OpenBiome Recent Developments/Updates
Table 88. MicroBiome Therapeutics Basic Information, Area Served and Competitors
Table 89. MicroBiome Therapeutics Major Business
Table 90. MicroBiome Therapeutics Faecal Microbiota Transplant(FMT) Therapy Product and Services
Table 91. MicroBiome Therapeutics Faecal Microbiota Transplant(FMT) Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 92. Global Key Players of Faecal Microbiota Transplant(FMT) Therapy Upstream (Raw Materials)
Table 93. Faecal Microbiota Transplant(FMT) Therapy Typical Customers
List of Figure
Figure 1. Faecal Microbiota Transplant(FMT) Therapy Picture
Figure 2. World Faecal Microbiota Transplant(FMT) Therapy Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Faecal Microbiota Transplant(FMT) Therapy Total Market Size (2018-2029) & (USD Million)
Figure 4. World Faecal Microbiota Transplant(FMT) Therapy Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Faecal Microbiota Transplant(FMT) Therapy Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Faecal Microbiota Transplant(FMT) Therapy Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Faecal Microbiota Transplant(FMT) Therapy Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Faecal Microbiota Transplant(FMT) Therapy Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Faecal Microbiota Transplant(FMT) Therapy Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Faecal Microbiota Transplant(FMT) Therapy Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Faecal Microbiota Transplant(FMT) Therapy Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Faecal Microbiota Transplant(FMT) Therapy Revenue (2018-2029) & (USD Million)
Figure 13. Faecal Microbiota Transplant(FMT) Therapy Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Faecal Microbiota Transplant(FMT) Therapy Consumption Value (2018-2029) & (USD Million)
Figure 16. World Faecal Microbiota Transplant(FMT) Therapy Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Faecal Microbiota Transplant(FMT) Therapy Consumption Value (2018-2029) & (USD Million)
Figure 18. China Faecal Microbiota Transplant(FMT) Therapy Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Faecal Microbiota Transplant(FMT) Therapy Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Faecal Microbiota Transplant(FMT) Therapy Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Faecal Microbiota Transplant(FMT) Therapy Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Faecal Microbiota Transplant(FMT) Therapy Consumption Value (2018-2029) & (USD Million)
Figure 23. India Faecal Microbiota Transplant(FMT) Therapy Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Faecal Microbiota Transplant(FMT) Therapy by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Faecal Microbiota Transplant(FMT) Therapy Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Faecal Microbiota Transplant(FMT) Therapy Markets in 2022
Figure 27. United States VS China: Faecal Microbiota Transplant(FMT) Therapy Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Faecal Microbiota Transplant(FMT) Therapy Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Faecal Microbiota Transplant(FMT) Therapy Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Faecal Microbiota Transplant(FMT) Therapy Market Size Market Share by Type in 2022
Figure 31. Oral
Figure 32. Enema
Figure 33. World Faecal Microbiota Transplant(FMT) Therapy Market Size Market Share by Type (2018-2029)
Figure 34. World Faecal Microbiota Transplant(FMT) Therapy Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 35. World Faecal Microbiota Transplant(FMT) Therapy Market Size Market Share by Application in 2022
Figure 36. Clostridioides Difficile Infection(CDI)
Figure 37. Digestive System Disease
Figure 38. Nervous System Disease
Figure 39. Others
Figure 40. Faecal Microbiota Transplant(FMT) Therapy Industrial Chain
Figure 41. Methodology
Figure 42. Research Process and Data Source
